research
The Biobank Called Back the Rare-Variant Carriers
A diverse health-system study measured what it takes to recruit people by genotype for deeper psychiatric assessment.
Summary
A diverse health-system study measured what it takes to recruit people by genotype for deeper psychiatric assessment.
Mount Sinai researchers invited 892 BioMe participants to follow-up studies: 335 carried rare copy-number variants linked to neurodevelopmental risk, 217 had schizophrenia without those variants, and 340 were controls. Eighteen percent responded and 8% completed detailed assessments, which revealed traits missed in routine records. The result is an operational benchmark for recall-by-genotype research, not a diagnostic program or evidence that a variant determines an individual outcome.
Why it matters
A diverse health-system study measured what it takes to recruit people by genotype for deeper psychiatric assessment.
Limits and context
- The result is an operational benchmark for recall-by-genotype research, not a diagnostic program or evidence that a variant determines an individual outcome.
Key claims
A diverse health-system study measured what it takes to recruit people by genotype for deeper psychiatric assessment.
Qualification: The result is an operational benchmark for recall-by-genotype research, not a diagnostic program or evidence that a variant determines an individual outcome.
Evidence: source-2026-07-24-010
Sources
- Mount Sinai via Newswise: Recall-by-genotype biobank studyMount Sinai via Newswise · secondary reporting
Corrections
No corrections have been recorded for this story.